Literature DB >> 3329126

Effect of the addition of simple sugars to mixed meals on the glycemic control of insulin treated diabetic patients.

M Buysschaert1, R Sory, M Mpoy, A E Lambert.   

Abstract

In order to evaluate the long term effects of a daily intake of simple sugars upon the glycemic control, 10 insulin treated diabetic outpatients received, according to a randomized cross over design, a conventional or a sucrose-enriched isocaloric, isoglucidic diet (about 20 g sucrose per day, given as desserts and/or soft drinks during or after mixed meals) for 3 months each. The daily insulin doses remained identical during both diets: 0.58 +/- 0.07 vs 0.58 +/- 0.06 U/kg body weight (mean +/- SEM) after conventional and sugar-enriched diet, respectively. The percentages of short acting insulin were also similar: 50 +/- 4 vs 49 +/- 4%. The mean glycemic profiles after lunch and dinner were comparable with both regimens. Moreover, glycosylated hemoglobin levels were 10.0 +/- 0.3 vs 9.9 +/- 0.4% after conventional and sucrose enriched diet, respectively. Plasma cholesterol and triglycerides remained unchanged. In conclusion, a relatively small daily intake of sucrose for 3 months has no clinical and/or metabolic side effects. Therefore, it seems no longer justified to completely ban sucrose from the diet of diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3329126

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  2 in total

1.  Effect of the introduction of dietary sucrose on metabolic control in children and adolescents with type I diabetes.

Authors:  J Schwingshandl; S Rippel; M Unterluggauer; M Borkenstein
Journal:  Acta Diabetol       Date:  1994-12       Impact factor: 4.280

2.  Food sources of fructose-containing sugars and glycaemic control: systematic review and meta-analysis of controlled intervention studies.

Authors:  Vivian L Choo; Effie Viguiliouk; Sonia Blanco Mejia; Adrian I Cozma; Tauseef A Khan; Vanessa Ha; Thomas M S Wolever; Lawrence A Leiter; Vladimir Vuksan; Cyril W C Kendall; Russell J de Souza; David J A Jenkins; John L Sievenpiper
Journal:  BMJ       Date:  2018-11-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.